SCHEMBL4308232

SCHEMBL4308232

CNC1CCN(C(=O)c2ccc(C=Cc3n[nH]c4ccccc34)c(NC(=O)c3sccc3C)c2)C1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AURKA O14965 3/20 0.55
▸ AURKB Q96GD4 3/20 0.55
▸ CDK7 P50613 4/20 0.40
▸ FLT3 P36888 3/20 0.40
▸ FGFR1 P11362 2/20 0.40
▸ BMPR1B O00238 1/20 0.40
▸ PLK4 O00444 1/20 0.40
▸ STK25 O00506 1/20 0.40
▸ CIT O14578 1/20 0.40
▸ RIOK3 O14730 1/20 0.40
▸ CHEK1 O14757 1/20 0.40
▸ IKBKB O14920 1/20 0.40
▸ GAK O14976 1/20 0.40
▸ DCLK1 O15075 1/20 0.40
▸ CHUK O15111 1/20 0.40
▸ MUSK O15146 1/20 0.40
▸ EPHB6 O15197 1/20 0.40
▸ PDPK1 O15530 1/20 0.40
▸ MAP3K13 O43283 1/20 0.40
▸ DAPK3 O43293 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4308218 1.00 AURKA (0.55) AURKAAURKBCDK7FLT3FGFR1
SCHEMBL4312157 0.91 AURKA (0.56) AURKAAURKBCDK7FLT3FGFR1
SCHEMBL4312152 0.91 AURKA (0.56) AURKAAURKBCDK7FLT3FGFR1
SCHEMBL4312141 0.91 AURKA (0.56) AURKAAURKBCDK7FLT3FGFR1
SCHEMBL4312146 0.91 AURKA (0.56) AURKAAURKBCDK7FLT3FGFR1
SCHEMBL4308969 0.91 AURKA (0.55) AURKAAURKBCDK7FLT3FGFR1
Hydrochloric Acid SCHEMBL4316905 0.91 AURKA (0.55) AURKAAURKBCDK7FLT3FGFR1
Hydrochloric Acid SCHEMBL4316916 0.91 AURKA (0.55) AURKAAURKBCDK7FLT3FGFR1
Hydrochloric Acid SCHEMBL4316911 0.91 AURKA (0.55) AURKAAURKBCDK7FLT3FGFR1
Hydrochloric Acid SCHEMBL4316915 0.91 AURKA (0.55) AURKAAURKBCDK7FLT3FGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7605272-B2 IGF-1R inhibitor KYOWA HAKKO KIRIN CO., LTD. (JP) 2009-10-20 — — US disclosed
US-20090054508-A1 IGF-1R INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-02-26 — — US disclosed
EP-1847532-A1 IGF-1R INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-10-24 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054508-A1 IGF-1R INHIBITOR IGF1R, IGFBP5, IGFBP1 AURKA 3687/4885AURKB 3438/4885CDK7 1410/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback